Clinical Trials Browser

Phase 2 × selpercatinib × Head & Neck × Clear all

NCT04759911 2025-11-13

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

Phase 2 Active not recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT04280081 2025-04-20

LIBRETTO-321

Phase 2 Active not recruiting

77 enrolled 13 charts

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Thyroid Neoplasms, Carcinoma, Medullary

NCT05668962 2024-12-12

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

Phase 2 Recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular